Symptomatic treatment of premenstrual syndrome and/or primary dysmenorrhea with DLBS1442, a bioactive extract of Phaleria macrocarpa

@inproceedings{Tjandrawinata2011SymptomaticTO,
  title={Symptomatic treatment of premenstrual syndrome and/or primary dysmenorrhea with DLBS1442, a bioactive extract of Phaleria macrocarpa},
  author={R R Tjandrawinata and Dwi Nofiarny and Liana W. Susanto and Prihatini Hendri and Audrey Clarissa},
  booktitle={International journal of general medicine},
  year={2011}
}
BACKGROUND DLBS1442, a proprietary and standardized semipolar bioactive extract of the fruit Phaleria macrocarpa, is preclinically proven to have anti-inflammatory properties. The current clinical study evaluated the efficacy and safety of DLBS1442 in alleviating symptoms of premenstrual syndrome and primary dysmenorrhea. METHODS This was an open study over four menstrual cycles (with two control cycles, followed by two treatment cycles). Women with premenstrual syndrome and/or primary… CONTINUE READING
Highly Cited
This paper has 32 citations. REVIEW CITATIONS